Related Experiment Videos
Tirapazamine (SR 4233) interrupts cell cycle progression and induces apoptosis
1Department of Radiation Oncology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.
Cancer Letters
|August 2, 1996
Summary
Tirapazamine (Tira) induces apoptosis in V79 cells under normal oxygen conditions. This understanding is crucial for its clinical use alongside radiotherapy, especially for radioresistant hypoxic tumors.
Area of Science:
- Cell Biology
- Pharmacology
- Radiotherapy Research
Background:
- Tirapazamine (Tira) is a bioreductive agent with known toxicity under hypoxic conditions.
- Its potential as an adjunct to radiotherapy for radioresistant hypoxic tumors is under active investigation.
- Understanding Tira's toxicity mechanisms under aerobic conditions is vital for safe clinical application.
Purpose of the Study:
- To investigate the cytotoxic mechanisms of Tirapazamine (Tira) in V79 cells under aerobic conditions.
- To assess the induction of apoptosis by Tira in normal oxygen environments.
Main Methods:
- Cytotoxicity assessed using colony formation assays.
- Cell growth inhibition evaluated with the MTT assay.
- Apoptosis induction analyzed via DNA fragmentation, flow cytometry, and microscopic observation.
Main Results:
- Tira treatment (100 microM for 2 h) resulted in approximately 78% cell survival.
- Mitotic cell counts decreased significantly after Tira exposure (100 microM for 4 h or 300 microM for 3 h).
- DNA fragmentation patterns indicative of apoptosis were observed after 300 microM Tira treatment for 2 h.
Conclusions:
- Tirapazamine induces apoptosis in V79 cells even under aerobic conditions.
- These apoptotic effects may contribute to Tira's overall toxicity, impacting both tumor and normal cells.
- Further research into Tira's mechanisms is necessary for optimizing its therapeutic use.